Egle Pavyde appointed as VP of Business Development at APICES CRO to drive global growth
We are thrilled to announce that Egle Pavyde has joined APICES CRO as Vice President of Business Development. With over 10 years of experience in the clinical trials field, she brings the expertise needed to help APICES’ clients achieve their research objectives across Europe and global markets.
With a background in pharmacy and a PhD in Life Sciences, Egle combines deep scientific knowledge with strong leadership and strategic insight. Throughout her career, she has successfully driven business growth, cultivated collaborations with pharmaceutical and biotech teams, and helped clients progress and achieve their clinical trial goals.
In her new role at APICES, she will focus on enhancing client engagement, expanding our service offerings, and guiding clients to accelerate their research programs. Her work will empower our clients to progress their studies effectively, ultimately contributing to the development of therapies that improve patient’s health and outcomes.
We are confident that Egle’s arrival will play a key role in strengthening APICES’ client partnerships and driving our growth, while helping clients achieve their research goals. We look forward to collaborating with our clients and partners to deliver high-quality clinical solutions and make a real difference in patients’ lives.
Interested in achieving your clinical research objectives? Contact APICES and discover how enables progress in clinical studies and improves patient outcomes.
